MacroGenics Acquires Raven Biotechnologies for Undisclosed Sum

  • Feed Type
  • Date
    7/17/2008
  • Company Name
    Raven Biotechnologies
  • Mailing Address
    One Corporate Drive South San Francisco, CA 94080
  • Company Description
    Raven’s approach creates the optimal starting point for developing a new drug with an increased probability of success in the clinic, within a substantially compressed time frame for drug lead development.
  • Website
    http://www.ravenbio.com/
  • Transaction Type
    M&A
  • Transaction Amount
    Undisclosed
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    MacroGenics will issue shares of its stock to purchase Raven. Other terms of the transaction were not disclosed.